Sharekhan

RPG Life Sciences Ltd

Wed 30/07/2025,15:59:13 NSE: RPGLIFE

₹ 2405.80 145.90 (6.46%)
BUY NOW Buy RPG Life Sciences Ltd Stock

Open Free Demat and Trading account in 15 minutes

Home Stock RPG Life Sciences Ltd

Wed 30/07/2025,16:1:0

RPG Life Sciences Ltd

Wed 30/07/2025,15:59:13 | NSE : RPGLIFE

₹ 2405.80145.90 (6.46%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 2289.00

Previous Close

₹ 2259.90

Volume

52510

Mkt Cap ( Rs. Cr)

₹3978.96

High

₹ 2474.50

Low

₹ 2249.40

52 Week High

₹ 2974.95

52 Week Low

₹ 1834.75

Book Value Per Share

₹ 229.39

Dividend Yield

1.06

Face Value

₹ 8.00

What’s Your Call?

Collective community sentiment on RPG Life Sciences Ltd

Your Vote -

Buy

55.56%

Hold

11.11%

Sell

33.33%

55.56%

9 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

100%

Sell Order Quantity

0%

Bid Price

Qty

2405.80

43

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

43

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts RPG Life Sciences Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • RPG Life Sciences - Copy of Newspaper Publication

    26 Jul 2025, 4:19PM Newspaper Publication of Financial result for Quarter ended June 2025

  • RPG Life Sciences - Outcome of Board Meeting

    25 Jul 2025, 8:30PM In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish t

  • RPG Life Sciences - General Updates

    25 Jul 2025, 8:16PM The Board at its meeting held on July 25, 2025 has approved amendment to the policy for determination of materiality of event

  • RPG Life Sciences - Amendment In Policy Of The Company

    25 Jul 2025, 8:13PM The Board at its meeting held on July 25, 2025 has approved amendment to the Policy for Determination of Materiality of Events.

  • RPG Life Sciences - Investor Presentation

    25 Jul 2025, 8:05PM RPG Life Sciences Limited has informed the Exchange about Investor Presentation

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation

    25 Jul 2025, 8:04PM Investor presentation for quarter ended on June 2025

  • RPG Life Sciences - Change in Management

    25 Jul 2025, 8:01PM Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, we wish t

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Change in Management

    25 Jul 2025, 8:01PM Pursuant to Regulation 30 of the SEBI LODR, 2015 we wish to inform you that, on the recommendation of NRC committee and Board approved appointment of

  • RPG Life Sciences - Press Release

    25 Jul 2025, 7:45PM RPG Life Sciences Limited has informed the Exchange regarding a press release dated July 25, 2025, titled ""Press release"".

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    25 Jul 2025, 7:44PM Press Release

  • RPG Life Sciences - Unaudited Financial Result For The Quarter Ended On June 30, 2025

    25 Jul 2025, 7:31PM Unaudited financial result for the quarter ended on June 30, 2025

  • RPG Life Sciences Q1 net profit down 1.76% at Rs 26.29 cr

    25 Jul 2025, 7:22PM The company reported standalone net profit of Rs 26.29 crore for the quarter ended June 30, 2025 as compared to Rs 26.76 crore in the same period last

  • RPG Life Sciences - Outcome of Board Meeting

    25 Jul 2025, 7:17PM outcome of Board meeting held on July 25, 2025

  • RPG Life Sciences - Board Meeting Outcome for Outcome Of The Board Meeting Held On July 25, 2025

    25 Jul 2025, 7:15PM In terms of Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and\r\nDisclosure Requirements) Regulations, 2015, we wis

  • RPG Life Sciences has submitted to BSE the Shareholding Pattern for the Period Ended June 30, 2025

    19 Jul 2025, 6:10PM As of June 2025, 72.95% is owned by Indian Promoters and 27.05% by Public. <p align=justify> Institutional holds 7.84% (Insurance Companies 0.21%) and

  • RPG Life Sciences - Board Meeting Intimation

    18 Jul 2025, 9:03PM RPG Life Sciences Limited has informed the Exchange about Board Meeting to be held on 25-Jul-2025 to inter-alia consider and approve the Unaudited Fin

  • RPG Life Sciences - Board Meeting Intimation for Board Meeting Intimation To Consider And Approve Unaudited Financial Results

    18 Jul 2025, 8:58PM RPG Life Sciences Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 25/07/2025 ,inter alia, to consider an

  • RPG Life Sciences - Copy of Newspaper Publication

    18 Jul 2025, 8:53PM Newspaper notice of Special Window for Re- lodgment of Physical Share Transfer of Request

  • RPG Life Sciences - Shareholders meeting

    16 Jul 2025, 9:50PM Details of Voting Results and Brief Proceedings of 17th Annual General Meeting of the Company

  • RPG Life Sciences - Voting Result Of 18Th Annual General Meeting

    16 Jul 2025, 9:48PM Details of Voting Result and Brief Proceedings of 18th Annual General Meeting of the Company

  • RPG Life Sciences - Shareholders meeting

    16 Jul 2025, 8:30PM Brief Proceedings, the voting results and Scrutinizer report of the Eighteenth Annual General Meeting of the Company.

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    16 Jul 2025, 8:27PM Brief of Proceedings, Voting result and Scrutinizer Report for 18th Annual General Meeting

  • RPG Life Sciences - Shareholders meeting

    16 Jul 2025, 8:22PM Brief Proceedings and details of the voting results of the Eighteenth Annual General Meeting of the Company

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    16 Jul 2025, 8:27PM Brief of Proceedings, Voting result and Scrutinizer Report for 18th Annual General Meeting

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    16 Jul 2025, 8:27PM Brief of Proceedings, Voting result and Scrutinizer Report for 18th Annual General Meeting

  • RPG Life Sciences - Shareholder Meeting / Postal Ballot-Scrutinizer's Report

    16 Jul 2025, 8:27PM Brief of Proceedings, Voting result and Scrutinizer Report for 18th Annual General Meeting

  • RPG Life Sciences - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    14 Jul 2025, 12:59PM We are enclosing herewith certificate dated July 04, 2025 issued by MUFG Intime India Private Limited, Registrar and Transfer Agents, confirming compl

  • RPG Life Sciences - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    14 Jul 2025, 12:57PM We are enclosing herewith certificate dated July 4, 2025 issued by MUFG Intime India Private Limited, Registrar and Transfer Agents, confirming compli

  • RPG Life Sciences - Trading Window-XBRL

    25 Jun 2025, 7:47PM RPG Life Sciences Limited has informed the Exchange about Closure of Trading Window

  • RPG Life Sciences - Trading Window

    25 Jun 2025, 7:46PM RPG Life Sciences Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations

  • RPG Life Sciences - General Updates

    24 Jun 2025, 6:40PM Pursuant to Regulation 36(1)(b) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the Company has sent a letter to those

  • RPG Life Sciences - Copy of Newspaper Publication

    24 Jun 2025, 6:38PM Pursuant to Regulation 30 of the SEBI (listing Obligations and Disclosure Requirements) Regulations, 2015, we enclose herewith the copy of Notice of 1

  • RPG Life Sciences - Intimation Under Regulation 30 Regarding Letter Dispatched To The Shareholders Of The Company

    24 Jun 2025, 6:36PM Pursuant to Regulation 36(1) (b) of the SEBI LODR, 2015, the company has sent the letter to those Members whose email addresses are not registered wit

  • RPG Life Sciences - Notice Of Shareholders Meetings-XBRL

    24 Jun 2025, 1:52PM RPG Life Sciences Limited has informed the Exchange about Notice of Shareholders Meeting for Annual General Meeting to be held on 16-Jul-2025

  • RPG Life Sciences - Shareholders meeting

    23 Jun 2025, 1:25PM RPG Life Sciences Limited has informed the Exchange regarding Notice of Annual General Meeting to be held on July 16, 2025

  • RPG Life Sciences - Business Responsibility and Sustainability Reporting (BRSR)

    23 Jun 2025, 1:56PM This is further to our letter dated June 14, 2025, conveying that the 18th AGM of the Company is Scheduled on Wednesday 16, 2025, through VC/OAVM mode

  • RPG Life Sciences - Reg. 34 (1) Annual Report.

    23 Jun 2025, 1:39PM This is further to our letter dated June 14, 2025, conveying 18th AGM of the Company is Scheduled on Wednesday July 16, 2025 Through VC/OAVM mode. Pur

  • RPG Life Sciences - Notice Of 18Th Annual General Meeting Scheduled On Wednesday, July 16, 2025.

    23 Jun 2025, 1:21PM The letter in further to our letter dated June 14, 2025, conveying that 18th Annual General Meeting of the Members of the company will be held on Wedn

  • RPG Life Sciences has declared 250% Final and 50% Special dividend for the financial year March 2025

    17 Jun 2025, 4:10PM RPG Life Sciences Ltd. on Tuesday, 29 April 2025, has announced Final dividend of 250 percent and Special dividend of 50 percent on Equity Share, to i

  • RPG Life Sciences - Copy of Newspaper Publication

    16 Jun 2025, 6:05PM RPG Life Sciences Ltd. has informed the Company about the Newspaper advertisement regarding Record date of 18th AGM

  • RPG Life Sciences - Outcome of Board Meeting-XBRL

    15 Jun 2025, 3:46PM RPG Life Sciences Limited has informed the Exchange regarding Outcome of Board Meeting held on 28-Apr-2025 for Dividend

  • RPG Life Sciences - Record Date

    14 Jun 2025, 4:01PM The Board of Directors at its meeting held on Monday, April 28, 2025, had recommended a final dividend of Rs.20 and additionally a special dividend of

  • RPG Life Sciences - Disclosure under SEBI Takeover Regulations

    13 Jun 2025, 6:52PM Swallow Associates LLP has Submitted to the Exchange a copy of Disclosure under Regulation 31(4) of the Securities and Exchange Board of India (Substa

  • RPG Life Sciences - Further To Our Letter Dated April 28, 2025 We Enclose Herewith Updated Annexure C Pursuant To Details Req

    3 Jun 2025, 9:58PM Update in Announcement filed on April 28, 2025 board meeting outcome.

  • RPG Life Sciences - Updates

    3 Jun 2025, 9:55PM RPG Life Sciences Limited has informed the Exchange regarding 'Update in announcement filed on April 28, 2025'.

  • RPG Life Sciences - General Updates

    3 Jun 2025, 9:51PM Pursuant to Regulation 30 of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, as amended, please find enclosed herewith a c

  • RPG Life Sciences - Intimation To Shareholders Holding Shares In Physical Mode Regarding Furnishing Of PAN, KYC Details And N

    3 Jun 2025, 9:50PM Pursuant to Regulation 30 of SEBI LODR, 2015 as amended please find enclosed letter copy dispatched to shareholders holding shares in physical mode in

  • RPG Life Sciences - Investor Presentation

    2 Jun 2025, 8:19PM RPG Life Sciences Limited has informed the Exchange about Investor Presentation

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Investor Presentation

    2 Jun 2025, 8:15PM In continuation of letter May 29, 2025 and pursuant to regulation 30 of SEBI LODR, 2015 the investor presentation which will be made during the RPG In

  • RPG Life Sciences - General Updates

    1 Jun 2025, 3:54PM In accordance with Regulation 30 of SEBI (Listing Obligations and DisclosureRequirements) Regulations, 2015 (""Listing Regulations""), we hereby enclo

  • RPG Life Sciences - In Accordance With Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2

    1 Jun 2025, 3:50PM Intimation letter to shareholders transfer of shares to IEPF Authority pursuant to transfer to IEPF

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    29 May 2025, 7:45PM Pursuant to Regulation 30 (6) read with Para A of Schedule III of the SEBI (Listing Obligations andDisclosure Requirements) Regulations, 2015, please

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    29 May 2025, 7:40PM Pursuant to 30 (6) read with para A of schedule III of SEBI LODR, 2015 for please find below the details of the Analyst/ Institutional investor meet t

  • RPG Life Sciences - Analysts/Institutional Investor Meet/Con. Call Updates

    5 May 2025, 6:32PM RPG Life Sciences Limited has informed the Exchange about Transcript

  • RPG Life Sciences - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    5 May 2025, 6:29PM Intimation of transcript of Results Earning Calls for Audited Financial Results for the Quarter ended on March 31, 2025 held on Tuesday 29th April, 20
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of RPG Life Sciences Ltd stock 

Name March-25 March-24 March-23 March-22 March-21
Assets 530.53 374.85 307.61 256.06 217.71
Liabilities 530.53 374.85 307.61 256.06 217.71
Equity 13.23 13.23 13.23 13.23 13.23
Gross Profit 159.65 128.15 102.69 86.36 69.93
Net Profit 183.24 87.66 67.64 51.48 40
Cash From Operating Activities 77.86 94.36 90.82 64.75 58.27
NPM(%) 28.04 15.06 13.19 11.69 10.27
Revenue 653.43 582.05 512.81 440.16 389.14
Expenses 493.78 453.9 410.12 353.8 319.21
ROE(%) 48.29 23.1 17.82 13.56 10.54

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day
27 Jun 2025 4 50 1 2091.3
27 Jun 2025 20 250 1 2174.5
28 Jun 2024 16 200 1 1546.4
14 Jul 2022 9.6 120 1 590.65
13 Aug 2021 7.2 90 1 485.1
24 Mar 2020 4 50 1 219.05
22 Jul 2019 2.4 30 1 234.7
19 Jul 2018 2.4 30 1 412.1
13 Jul 2017 2.8 35 1 440.15
22 Mar 2016 1.6 20 1 252.3
20 Jul 2015 0.8 10 1 140.15
11 Sep 2014 1.2 15 1 70.6
11 Jul 2013 1.2 15 1 61.55
24 Jul 2012 0.8 10 1 64
14 Jul 2011 1.6 20 1 80
15 Jul 2010 1.44 18 1 70.65
30 Jul 2009 1.2 15 1 31.35
11 Aug 2008 1.2 15 1 25.75

Peers

Other companies within the same industry or sector that are comparable to RPG Life Sciences Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 895.40 -1.33 29.71 1282.87 301.39 0.56
Lotus Eye Hospital and Institute Ltd 72.74 -1.49 207.83 4674.59 3.55 0.00
Vaishali Pharma Ltd 12.43 0.89 207.17 2409.46 3.13 0.00
Astec Lifesciences Ltd 864.50 -0.98 0.00 4408.25 -601.21 0.00

Company Info

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

2009 - Rpg Life Sciences Limited has informed that Mr. Ankur Kumar has been appointed as Controller - Legal & Company Secretary and Compliance Officer of the Company with effect from January 08, 2009. 2010 - Mr. Ajit Singh Chouhan, presently a Director of the Company has been appointed as Managing Director of the Company. - Mr. Sachin Raole, General Manager Finance has been designated as Chief Financial Officer (CFO) of the Company. 2011 - RPG Life Sciences launches dialysis deferring drug. - Mr. Rajesh Shirambekar has been appointed as Head - Legal & Company Secretary and Compliance Officer of the Company. 2012 -Board has recommended an equity dividend of Rs. 0.80 per share (10%). 2013 -RPG Life Sciences Ltd received 'EUGMP certification' for its Navi Mumbai API facility." -RPG Life Sciences bagged "Asia's Best Employer Brand Awards 2013" in Singapore. 2014 -Board has recommended a total dividend of Rs. 2.00 per share (25%) for the year 2014. 2015 -RPG Life Plans Skincare Foray 2016 -RPG Life Sciences - RPG Life Sciences announces foray into Cosmetic Industry -RPG Life gains over 14 pct on getting EUGMP certification -RPG Life Sciences - RPG Life Sciences to expand its formulations business 2019 -RPG Life Sciences enters Anti-Diabetic therapeutic area.

Read More

Parent Organisation

RPG Life Sciences Ltd.

Founded

29/03/2007

Managing Director

Mr.Ashok Nair

NSE Symbol

RPGLIFEEQ

FAQ

The current price of RPG Life Sciences Ltd is ₹ 2405.80.

The 52-week high for RPG Life Sciences Ltd is ₹ 2474.50 and the 52-week low is ₹ 2249.40.

The market capitalization of RPG Life Sciences Ltd is currently ₹ 3978.96. This value can fluctuate based on stock price movements and changes in the number of shares outstanding.

To buy RPG Life Sciences Ltd shares, you need to have a brokerage account. First, choose a reputable brokerage firm, open an account, and complete the necessary KYC procedures.

To invest in RPG Life Sciences Ltd, you need a brokerage account. After opening an account and completing the KYC process, you can fund your account and use the trading platform to purchase RPG Life Sciences Ltd shares.

The CEO of RPG Life Sciences Ltd is Mr.Ashok Nair, who has been leading the company with a vision to expand its renewable energy portfolio and drive sustainable growth.

OPEN FREE* DEMAT ACCOUNT